{"id":"W3194633883","doi":"10.1016/j.annonc.2021.06.012","title":"LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; TIGIT; Oncology; Esophageal cancer; Immunotherapy; Internal medicine; Cancer; Lung cancer; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001596622,0.001419749,0.002225907,0.0005109576,0.0004650371,0.001507967,0.001056363,0.001281946,0.003480977],"category_scores_gemma":[0.0006493159,0.0006954378,0.002923603,0.0004066806,0.000990816,0.0009302842,0.0004598685,0.004379034,0.001028336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001568446,"about_ca_system_score_gemma":0.001663553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002335103,"about_ca_topic_score_gemma":0.008167099,"domain_scores_codex":[0.9995864,0.0001792054,0.00001989554,0.0000560206,0.00003443741,0.0001240634],"domain_scores_gemma":[0.9996574,0.00004528044,0.00005251821,0.0000273806,0.00002204563,0.00019531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6635832,0.06456532,0.009279399,0.002372976,0.005463793,0.000456613,0.0004795995,0.005949208,0.0513999,0.00105979,0.009488439,0.1859017],"study_design_scores_gemma":[0.4782009,0.4878891,0.01588284,0.0001216392,0.001859422,0.0003904362,0.000176957,0.002631661,0.004343236,0.0002553315,0.008189768,0.0000586268],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829313,0.007686232,0.0008333576,0.001220934,0.0004695724,0.001539027,0.001140011,0.0001976873,0.003981913],"genre_scores_gemma":[0.9853233,0.003691896,0.00175364,0.001375181,0.000239199,0.001238843,0.002566729,0.00003513398,0.003776105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003480977,"threshold_uncertainty_score":0.01164502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04275491701376318,"score_gpt":0.3940639982676488,"score_spread":0.3513090812538856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}